Importer of Controlled Substances Application: Research Triangle Institute, 2571-2575 [2019-01523]

Download as PDF 2571 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices Drug code Controlled substance Beta-hydroxythiofentanyl ......................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................................. Amphetamine ........................................................................................................................................................................... Methamphetamine ................................................................................................................................................................... Codeine ................................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................................ Oxycodone ............................................................................................................................................................................... Hydromorphone ....................................................................................................................................................................... Hydrocodone ........................................................................................................................................................................... Isomethadone .......................................................................................................................................................................... Methadone ............................................................................................................................................................................... Methadone intermediate .......................................................................................................................................................... Morphine .................................................................................................................................................................................. Thebaine .................................................................................................................................................................................. Levo-alphacetylmethadol ......................................................................................................................................................... Oxymorphone .......................................................................................................................................................................... Thiafentanil .............................................................................................................................................................................. Alfentanil .................................................................................................................................................................................. Sufentanil ................................................................................................................................................................................. Carfentanil ............................................................................................................................................................................... Fentanyl ................................................................................................................................................................................... The company plans to manufacture the listed controlled substances to make reference standards which will be distributed to their customers. Dated: December 21, 2018. John J. Martin, Assistant Administrator. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration [FR Doc. 2019–01510 Filed 2–6–19; 8:45 am] ACTION: Notice of registration. BILLING CODE 4410–09–P The registrant listed below has applied for and been granted a SUMMARY: FR Docket Sigma Aldrich Co., LLC ................................................................................................................................. 83 FR 60903 VerDate Sep<11>2014 17:23 Feb 06, 2019 Jkt 247001 Dated: January 3, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–01521 Filed 2–6–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Research Triangle Institute ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 11, 2019. Such persons may also file a written request for a DATES: PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 I I II II II II II II II II II II II II II II II II II II II registration by the Drug Enforcement Administration (DEA) as an importer of schedule I and II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice. Company The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security system, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and II controlled substances to the above listed company. 9836 9843 1100 1105 9050 9120 9143 9150 9193 9226 9250 9254 9300 9333 9648 9652 9729 9737 9740 9743 9801 Schedule Published November 27, 2018. hearing on the application on or before March 11, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to E:\FR\FM\07FEN1.SGM 07FEN1 2572 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on May 2, 2016, Research Triangle Institute, 3040 East Cornwallis Road, Hermann Bldg., Room 106, Research Triangle Park, North Carolina 27709 has applied to be registered as an importer of the following basic classes of controlled substances. Drug code Controlled substance 3-Fluoro-N-methylcathinone (3-FMC) ...................................................................................................................................... Cathinone ................................................................................................................................................................................ Methcathinone ......................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4-FMC) ...................................................................................................................................... Pentedrone (a-methylaminovalerophenone) ........................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................................ 4-Methyl-N-ethylcathinone (4-MEC) ........................................................................................................................................ Naphyrone ............................................................................................................................................................................... N-Ethylamphetamine ............................................................................................................................................................... N,N-Dimethylamphetamine ...................................................................................................................................................... Fenethylline ............................................................................................................................................................................. Aminorex .................................................................................................................................................................................. 4-Methylaminorex (cis isomer) ................................................................................................................................................ Gamma Hydroxybutyric Acid ................................................................................................................................................... Methaqualone .......................................................................................................................................................................... Mecloqualone .......................................................................................................................................................................... JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................................... SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ......................................................... 5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ......................... AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............................. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ............................................................................................................................... AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole3-carboxamide) ................................................... THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ............................................................................ AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)1H-indazole-3-carboxamide ........................... MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................. ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .......................................... APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ...................................................................... JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ........................................................................................................... SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .............................................................................. JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................................... JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................................. UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .......................................................................... JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ................................................................................................................................ JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................................... JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................................. PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .......................................................................................................... 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ...................................................................................... Alpha-ethyltryptamine .............................................................................................................................................................. Ibogaine ................................................................................................................................................................................... CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................................... CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................... Lysergic acid diethylamide ...................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ........................................................................................................ Marihuana ................................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................................ Parahexyl ................................................................................................................................................................................. Mescaline ................................................................................................................................................................................. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) .................................................................................................... 3,4,5-Trimethoxyamphetamine ................................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ..................................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ..................................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................................... JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................................. 2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................................ 3,4-Methylenedioxyamphetamine ............................................................................................................................................ 5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................... 3,4-Methylenedioxymethamphetamine .................................................................................................................................... 4-Methoxyamphetamine .......................................................................................................................................................... Peyote ...................................................................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine ......................................................................................................................................... VerDate Sep<11>2014 18:55 Feb 06, 2019 Jkt 247001 PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM 07FEN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 1585 1590 2010 2565 2572 6250 7008 7011 7012 7019 7023 7024 7031 7032 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 7315 7348 7360 7370 7374 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7415 7431 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 2573 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices Drug code Controlled substance Alpha-methyltryptamine ........................................................................................................................................................... Bufotenine ................................................................................................................................................................................ Diethyltryptamine ..................................................................................................................................................................... Dimethyltryptamine .................................................................................................................................................................. Psilocybin ................................................................................................................................................................................. Psilocyn ................................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ..................................................................................................................................... N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................................ 1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................................ 1-[1-(2-Thienyl)cyclohexyl]piperidine ....................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ...................................................................................................................................... N-Ethyl-3-piperidyl benzilate .................................................................................................................................................... N-Methyl-3-piperidyl benzilate ................................................................................................................................................. N-Benzylpiperazine .................................................................................................................................................................. 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ............................................................................................................. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) .......................................................................................................... 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ............................................................................................................ 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ......................................................................................................................... 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ................................................................................................................ 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ........................................................................................................... 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) ............................................................................................................. 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ...................................................................................................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) ............................................................................................ MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) ............................................................. 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) ............................................................. 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) .................................................................. Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................................. Butylone ................................................................................................................................................................................... Pentylone ................................................................................................................................................................................. alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................................. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ............................................................................................................ Acetyldihydrocodeine ............................................................................................................................................................... Benzylmorphine ....................................................................................................................................................................... Codeine-N-oxide ...................................................................................................................................................................... Cyprenorphine ......................................................................................................................................................................... Desomorphine ......................................................................................................................................................................... Etorphine (except HCl) ............................................................................................................................................................ Codeine methylbromide ........................................................................................................................................................... Dihydromorphine ..................................................................................................................................................................... Difenoxin .................................................................................................................................................................................. Heroin ...................................................................................................................................................................................... Hydromorphinol ....................................................................................................................................................................... Methyldesorphine .................................................................................................................................................................... Methyldihydromorphine ........................................................................................................................................................... Morphine methylbromide ......................................................................................................................................................... Morphine methylsulfonate ....................................................................................................................................................... Morphine-N-oxide .................................................................................................................................................................... Myrophine ................................................................................................................................................................................ Nicocodeine ............................................................................................................................................................................. Nicomorphine ........................................................................................................................................................................... Normorphine ............................................................................................................................................................................ Pholcodine ............................................................................................................................................................................... Thebacon ................................................................................................................................................................................. Acetorphine .............................................................................................................................................................................. Drotebanol ............................................................................................................................................................................... Acetylmethadol ........................................................................................................................................................................ Allylprodine .............................................................................................................................................................................. Alphacetylmethadol except levo-alphacetylmethadol .............................................................................................................. Alphameprodine ....................................................................................................................................................................... Alphamethadol ......................................................................................................................................................................... Benzethidine ............................................................................................................................................................................ Betacetylmethadol ................................................................................................................................................................... Betameprodine ........................................................................................................................................................................ Betamethadol ........................................................................................................................................................................... Betaprodine ............................................................................................................................................................................. Clonitazene .............................................................................................................................................................................. Dextromoramide ...................................................................................................................................................................... Diampromide ........................................................................................................................................................................... Diethylthiambutene .................................................................................................................................................................. Dimenoxadol ............................................................................................................................................................................ Dimepheptanol ......................................................................................................................................................................... VerDate Sep<11>2014 18:55 Feb 06, 2019 Jkt 247001 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM 07FEN1 7432 7433 7434 7435 7437 7438 7439 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 9051 9052 9053 9054 9055 9056 9070 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 9319 9335 9601 9602 9603 9604 9605 9606 9607 9608 9609 9611 9612 9613 9615 9616 9617 9618 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 2574 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices Drug code Controlled substance Dimethylthiambutene ............................................................................................................................................................... Dioxaphetyl butyrate ................................................................................................................................................................ Dipipanone ............................................................................................................................................................................... Ethylmethylthiambutene .......................................................................................................................................................... Etonitazene .............................................................................................................................................................................. Etoxeridine ............................................................................................................................................................................... Furethidine ............................................................................................................................................................................... Hydroxypethidine ..................................................................................................................................................................... Ketobemidone .......................................................................................................................................................................... Levomoramide ......................................................................................................................................................................... Levophenacylmorphan ............................................................................................................................................................ Morpheridine ............................................................................................................................................................................ Noracymethadol ....................................................................................................................................................................... Norlevorphanol ........................................................................................................................................................................ Normethadone ......................................................................................................................................................................... Norpipanone ............................................................................................................................................................................ Phenadoxone ........................................................................................................................................................................... Phenampromide ...................................................................................................................................................................... Phenoperidine .......................................................................................................................................................................... Piritramide ................................................................................................................................................................................ Proheptazine ............................................................................................................................................................................ Properidine .............................................................................................................................................................................. Racemoramide ........................................................................................................................................................................ Trimeperidine ........................................................................................................................................................................... Phenomorphan ........................................................................................................................................................................ Propiram .................................................................................................................................................................................. 1-Methyl-4-phenyl-4-propionoxypiperidine .............................................................................................................................. 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ...................................................................................................................... Tilidine ..................................................................................................................................................................................... Para-Fluorofentanyl ................................................................................................................................................................. 3-Methylfentanyl ...................................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................................... Acetyl-alpha-methylfentanyl ..................................................................................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................................... Butyryl Fentanyl ....................................................................................................................................................................... Beta-hydroxyfentanyl ............................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ................................................................................................................................................ Alpha-methylthiofentanyl ......................................................................................................................................................... 3-Methylthiofentanyl ................................................................................................................................................................. Thiofentanyl ............................................................................................................................................................................. Amphetamine ........................................................................................................................................................................... Methamphetamine ................................................................................................................................................................... Lisdexamfetamine .................................................................................................................................................................... Phenmetrazine ......................................................................................................................................................................... Methylphenidate ...................................................................................................................................................................... Amobarbital .............................................................................................................................................................................. Pentobarbital ............................................................................................................................................................................ Secobarbital ............................................................................................................................................................................. Glutethimide ............................................................................................................................................................................. Nabilone ................................................................................................................................................................................... 1-Phenylcyclohexylamine ........................................................................................................................................................ Phencyclidine ........................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ............................................................................................................................. Phenylacetone ......................................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile ........................................................................................................................................ Alphaprodine ............................................................................................................................................................................ Anileridine ................................................................................................................................................................................ Coca Leaves ............................................................................................................................................................................ Cocaine .................................................................................................................................................................................... Codeine ................................................................................................................................................................................... Etorphine HCl .......................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................................ Oxycodone ............................................................................................................................................................................... Hydromorphone ....................................................................................................................................................................... Diphenoxylate .......................................................................................................................................................................... Ecgonine .................................................................................................................................................................................. Ethylmorphine .......................................................................................................................................................................... Hydrocodone ........................................................................................................................................................................... Levomethorphan ...................................................................................................................................................................... Levorphanol ............................................................................................................................................................................. Isomethadone .......................................................................................................................................................................... Meperidine ............................................................................................................................................................................... Meperidine intermediate-A ...................................................................................................................................................... VerDate Sep<11>2014 18:55 Feb 06, 2019 Jkt 247001 PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM 07FEN1 9619 9621 9622 9623 9624 9625 9626 9627 9628 9629 9631 9632 9633 9634 9635 9636 9637 9638 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9812 9813 9814 9815 9821 9822 9830 9831 9832 9833 9835 1100 1105 1205 1631 1724 2125 2270 2315 2550 7379 7460 7471 8333 8501 8603 9010 9020 9040 9041 9050 9059 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II 2575 Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices Drug code Controlled substance Meperidine intermediate-B ...................................................................................................................................................... Meperidine intermediate-C ...................................................................................................................................................... Metazocine .............................................................................................................................................................................. Methadone ............................................................................................................................................................................... Methadone intermediate .......................................................................................................................................................... Metopon ................................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................................... Morphine .................................................................................................................................................................................. Oripavine ................................................................................................................................................................................. Thebaine .................................................................................................................................................................................. Dihydroetorphine ..................................................................................................................................................................... Opium, raw .............................................................................................................................................................................. Opium extracts ........................................................................................................................................................................ Opium fluid extract .................................................................................................................................................................. Opium tincture ......................................................................................................................................................................... Opium, powdered .................................................................................................................................................................... Opium, granulated ................................................................................................................................................................... Levo-alphacetylmethadol ......................................................................................................................................................... Opium poppy ........................................................................................................................................................................... Oxymorphone .......................................................................................................................................................................... Noroxymorphone ..................................................................................................................................................................... Poppy Straw Concentrate ....................................................................................................................................................... Phenazocine ............................................................................................................................................................................ Piminodine ............................................................................................................................................................................... Racemethorphan ..................................................................................................................................................................... Racemorphan .......................................................................................................................................................................... Alfentanil .................................................................................................................................................................................. Remifentanil ............................................................................................................................................................................. Sufentanil ................................................................................................................................................................................. Carfentanil ............................................................................................................................................................................... Tapentadol ............................................................................................................................................................................... Bezitramide .............................................................................................................................................................................. Fentanyl ................................................................................................................................................................................... Moramide-intermediate ............................................................................................................................................................ The company plans to import small quantities of the listed controlled substances for the National Institute on Drug Abuse (NIDA) for research activities. The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Dated: January 2, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–01523 Filed 2–6–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Microgenics Corporation Thermo Fisher Scientific ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and DATES: applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 11, 2019. Such persons may also file a written request for a hearing on the application on or before March 11, 2019. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his SUPPLEMENTARY INFORMATION: Drug code Cathinone ................................................................................................................................................................................ 18:55 Feb 06, 2019 Jkt 247001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on October 23, 2018, Microgenics Corporation/ Thermo Fisher Scientific located at 46500 Kato Rd., Fremont, California 94538, applied to be registered as an importer of the below listed basic classes of controlled substance listed in schedules I and II. Controlled substance VerDate Sep<11>2014 9233 9234 9240 9250 9254 9260 9273 9300 9330 9333 9334 9600 9610 9620 9630 9639 9640 9648 9650 9652 9668 9670 9715 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 Schedule E:\FR\FM\07FEN1.SGM 07FEN1 1235 Schedule I

Agencies

[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2571-2575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01523]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Research Triangle 
Institute

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before March 11, 2019. Such 
persons may also file a written request for a hearing on the 
application on or before March 11, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to

[[Page 2572]]

exercise all necessary functions with respect to the promulgation and 
implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on May 2, 
2016, Research Triangle Institute, 3040 East Cornwallis Road, Hermann 
Bldg., Room 106, Research Triangle Park, North Carolina 27709 has 
applied to be registered as an importer of the following basic classes 
of controlled substances.

------------------------------------------------------------------------
            Controlled substance              Drug code      Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)..........       1233  I
Cathinone...................................       1235  I
Methcathinone...............................       1237  I
4-Fluoro-N-methylcathinone (4-FMC)..........       1238  I
Pentedrone ([alpha]-                               1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone).....       1248  I
4-Methyl-N-ethylcathinone (4-MEC)...........       1249  I
Naphyrone...................................       1258  I
N-Ethylamphetamine..........................       1475  I
N,N-Dimethylamphetamine.....................       1480  I
Fenethylline................................       1503  I
Aminorex....................................       1585  I
4-Methylaminorex (cis isomer)...............       1590  I
Gamma Hydroxybutyric Acid...................       2010  I
Methaqualone................................       2565  I
Mecloqualone................................       2572  I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)        6250  I
 indole).
SR-18 (Also known as RCS-8) (1-                    7008  I
 Cyclohexylethyl-3-(2-methoxyphenylacetyl)
 indole).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-            7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-       7012  I
 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
 carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).....       7019  I
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-       7023  I
 yl)-1-pentyl-1H-indazole3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-         7024  I
 yl](naphthalen-1-yl)methanone.
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-       7031  I
 2-yl)-1-(cyclohexylmethyl)1H-indazole-3-
 carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-            7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-             7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-        7048  I
 1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)        7081  I
 indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-       7104  I
 methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-Pentyl-3-(1-      7118  I
 naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)         7122  I
 indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-           7144  I
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).....       7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-          7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)         7201  I
 indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)         7203  I
 indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-         7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-        7225  I
 1H-indole-3-carboxylate).
Alpha-ethyltryptamine.......................       7249  I
Ibogaine....................................       7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-      7297  I
 3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                    7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide..................       7315  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine       7348  I
 (2C-T-7).
Marihuana...................................       7360  I
Tetrahydrocannabinols.......................       7370  I
Parahexyl...................................       7374  I
Mescaline...................................       7381  I
2-(4-Ethylthio-2,5-dimethoxyphenyl)                7385  I
 ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine.................       7390  I
4-Bromo-2,5-dimethoxyamphetamine............       7391  I
4-Bromo-2,5-dimethoxyphenethylamine.........       7392  I
4-Methyl-2,5-dimethoxyamphetamine...........       7395  I
2,5-Dimethoxyamphetamine....................       7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)         7398  I
 indole).
2,5-Dimethoxy-4-ethylamphetamine............       7399  I
3,4-Methylenedioxyamphetamine...............       7400  I
5-Methoxy-3,4-methylenedioxyamphetamine.....       7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine.....       7402  I
3,4-Methylenedioxy-N-ethylamphetamine.......       7404  I
3,4-Methylenedioxymethamphetamine...........       7405  I
4-Methoxyamphetamine........................       7411  I
Peyote......................................       7415  I
5-Methoxy-N-N-dimethyltryptamine............       7431  I

[[Page 2573]]

 
Alpha-methyltryptamine......................       7432  I
Bufotenine..................................       7433  I
Diethyltryptamine...........................       7434  I
Dimethyltryptamine..........................       7435  I
Psilocybin..................................       7437  I
Psilocyn....................................       7438  I
5-Methoxy-N,N-diisopropyltryptamine.........       7439  I
N-Ethyl-1-phenylcyclohexylamine.............       7455  I
1-(1-Phenylcyclohexyl)pyrrolidine...........       7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine.......       7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine......       7473  I
N-Ethyl-3-piperidyl benzilate...............       7482  I
N-Methyl-3-piperidyl benzilate..............       7484  I
N-Benzylpiperazine..........................       7493  I
4-Methyl-alphapyrrolidinopropiophenone (4-         7498  I
 MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine        7508  I
 (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine         7509  I
 (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)...       7517  I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine          7518  I
 (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine        7519  I
 (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine        7521  I
 (2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl)               7524  I
 ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl)           7532  I
 ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone).......       7535  I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-              7536  I
 methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-             7537  I
 methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-               7538  I
 methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N-                   7540  I
 methylcathinone).
Butylone....................................       7541  I
Pentylone...................................       7542  I
alpha-pyrrolidinopentiophenone ([alpha]-PVP)       7545  I
alpha-pyrrolidinobutiophenone ([alpha]-PBP).       7546  I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)       7694  I
 indole).
Acetyldihydrocodeine........................       9051  I
Benzylmorphine..............................       9052  I
Codeine-N-oxide.............................       9053  I
Cyprenorphine...............................       9054  I
Desomorphine................................       9055  I
Etorphine (except HCl)......................       9056  I
Codeine methylbromide.......................       9070  I
Dihydromorphine.............................       9145  I
Difenoxin...................................       9168  I
Heroin......................................       9200  I
Hydromorphinol..............................       9301  I
Methyldesorphine............................       9302  I
Methyldihydromorphine.......................       9304  I
Morphine methylbromide......................       9305  I
Morphine methylsulfonate....................       9306  I
Morphine-N-oxide............................       9307  I
Myrophine...................................       9308  I
Nicocodeine.................................       9309  I
Nicomorphine................................       9312  I
Normorphine.................................       9313  I
Pholcodine..................................       9314  I
Thebacon....................................       9315  I
Acetorphine.................................       9319  I
Drotebanol..................................       9335  I
Acetylmethadol..............................       9601  I
Allylprodine................................       9602  I
Alphacetylmethadol except levo-                    9603  I
 alphacetylmethadol.
Alphameprodine..............................       9604  I
Alphamethadol...............................       9605  I
Benzethidine................................       9606  I
Betacetylmethadol...........................       9607  I
Betameprodine...............................       9608  I
Betamethadol................................       9609  I
Betaprodine.................................       9611  I
Clonitazene.................................       9612  I
Dextromoramide..............................       9613  I
Diampromide.................................       9615  I
Diethylthiambutene..........................       9616  I
Dimenoxadol.................................       9617  I
Dimepheptanol...............................       9618  I

[[Page 2574]]

 
Dimethylthiambutene.........................       9619  I
Dioxaphetyl butyrate........................       9621  I
Dipipanone..................................       9622  I
Ethylmethylthiambutene......................       9623  I
Etonitazene.................................       9624  I
Etoxeridine.................................       9625  I
Furethidine.................................       9626  I
Hydroxypethidine............................       9627  I
Ketobemidone................................       9628  I
Levomoramide................................       9629  I
Levophenacylmorphan.........................       9631  I
Morpheridine................................       9632  I
Noracymethadol..............................       9633  I
Norlevorphanol..............................       9634  I
Normethadone................................       9635  I
Norpipanone.................................       9636  I
Phenadoxone.................................       9637  I
Phenampromide...............................       9638  I
Phenoperidine...............................       9641  I
Piritramide.................................       9642  I
Proheptazine................................       9643  I
Properidine.................................       9644  I
Racemoramide................................       9645  I
Trimeperidine...............................       9646  I
Phenomorphan................................       9647  I
Propiram....................................       9649  I
1-Methyl-4-phenyl-4-propionoxypiperidine....       9661  I
1-(2-Phenylethyl)-4-phenyl-4-                      9663  I
 acetoxypiperidine.
Tilidine....................................       9750  I
Para-Fluorofentanyl.........................       9812  I
3-Methylfentanyl............................       9813  I
Alpha-methylfentanyl........................       9814  I
Acetyl-alpha-methylfentanyl.................       9815  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-        9821  I
 yl)-N-phenylacetamide).
Butyryl Fentanyl............................       9822  I
Beta-hydroxyfentanyl........................       9830  I
Beta-hydroxy-3-methylfentanyl...............       9831  I
Alpha-methylthiofentanyl....................       9832  I
3-Methylthiofentanyl........................       9833  I
Thiofentanyl................................       9835  I
Amphetamine.................................       1100  II
Methamphetamine.............................       1105  II
Lisdexamfetamine............................       1205  II
Phenmetrazine...............................       1631  II
Methylphenidate.............................       1724  II
Amobarbital.................................       2125  II
Pentobarbital...............................       2270  II
Secobarbital................................       2315  II
Glutethimide................................       2550  II
Nabilone....................................       7379  II
1-Phenylcyclohexylamine.....................       7460  II
Phencyclidine...............................       7471  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)...       8333  II
Phenylacetone...............................       8501  II
1-Piperidinocyclohexanecarbonitrile.........       8603  II
Alphaprodine................................       9010  II
Anileridine.................................       9020  II
Coca Leaves.................................       9040  II
Cocaine.....................................       9041  II
Codeine.....................................       9050  II
Etorphine HCl...............................       9059  II
Dihydrocodeine..............................       9120  II
Oxycodone...................................       9143  II
Hydromorphone...............................       9150  II
Diphenoxylate...............................       9170  II
Ecgonine....................................       9180  II
Ethylmorphine...............................       9190  II
Hydrocodone.................................       9193  II
Levomethorphan..............................       9210  II
Levorphanol.................................       9220  II
Isomethadone................................       9226  II
Meperidine..................................       9230  II
Meperidine intermediate-A...................       9232  II

[[Page 2575]]

 
Meperidine intermediate-B...................       9233  II
Meperidine intermediate-C...................       9234  II
Metazocine..................................       9240  II
Methadone...................................       9250  II
Methadone intermediate......................       9254  II
Metopon.....................................       9260  II
Dextropropoxyphene, bulk (non-dosage forms).       9273  II
Morphine....................................       9300  II
Oripavine...................................       9330  II
Thebaine....................................       9333  II
Dihydroetorphine............................       9334  II
Opium, raw..................................       9600  II
Opium extracts..............................       9610  II
Opium fluid extract.........................       9620  II
Opium tincture..............................       9630  II
Opium, powdered.............................       9639  II
Opium, granulated...........................       9640  II
Levo-alphacetylmethadol.....................       9648  II
Opium poppy.................................       9650  II
Oxymorphone.................................       9652  II
Noroxymorphone..............................       9668  II
Poppy Straw Concentrate.....................       9670  II
Phenazocine.................................       9715  II
Piminodine..................................       9730  II
Racemethorphan..............................       9732  II
Racemorphan.................................       9733  II
Alfentanil..................................       9737  II
Remifentanil................................       9739  II
Sufentanil..................................       9740  II
Carfentanil.................................       9743  II
Tapentadol..................................       9780  II
Bezitramide.................................       9800  II
Fentanyl....................................       9801  II
Moramide-intermediate.......................       9802  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the National Institute on Drug Abuse (NIDA) 
for research activities. The company plans to import analytical 
reference standards for distribution to its customers for research and 
analytical purposes.

    Dated: January 2, 2019.
 John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01523 Filed 2-6-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.